Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI, Madejón A, Francisco-Recuero I, López-López A, Villafranca E, Romero M, García A, Olveira A, Mena R, Larrubia JR, García-Samaniego J.
Gil-García AI, et al. Among authors: romero m.
World J Gastroenterol. 2019 Oct 14;25(38):5883-5896. doi: 10.3748/wjg.v25.i38.5883.
World J Gastroenterol. 2019.
PMID: 31636479
Free PMC article.